Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
18
CMCT Quote, Financials, Valuation and Earnings
Last price:
$7.31
Seasonality move
:
-7.5%
Day range:
$7.07 - $7.46
52-week range:
$4.03 - $634.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.02x
P/B ratio:
--
Volume:
10.8K
Avg. volume:
13.7K
1-year change:
-98.67%
Market cap:
$5.5M
Revenue:
$124.5M
EPS (TTM):
-$475.61
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $77.2M | $90.9M | $101.9M | $119.3M | $124.5M | |
| Revenue Growth (YoY) | -44.85% | 17.77% | 12.08% | 17.03% | 4.41% | |
| Cost of Revenues | $43.3M | $43.2M | $54.4M | $67.4M | $72.8M | |
| Gross Profit | $33.9M | $47.7M | $47.5M | $51.8M | $51.7M | |
| Gross Profit Margin | 43.95% | 52.44% | 46.64% | 43.47% | 41.52% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $16.6M | $15.9M | $10.4M | $10.7M | $8.8M | |
| Other Inc / (Exp) | -$281K | -$143K | -$59K | -$3.7M | -$3.6M | |
| Operating Expenses | $38M | $36M | $30.8M | $63.2M | $36.2M | |
| Operating Income | -$4M | $11.7M | $16.7M | -$11.4M | $15.5M | |
| Net Interest Expenses | $11.4M | $9.4M | $9.6M | $35.1M | $36.9M | |
| EBT. Incl. Unusual Items | -$15.7M | $2.1M | $7.1M | -$50.2M | -$25M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$722K | $3M | $1.1M | $1.2M | $798K | |
| Net Income to Company | -$15M | -$851K | $5.9M | -$51.5M | -$25.8M | |
| Minority Interest in Earnings | -$1K | $1K | -$27K | $3M | $575K | |
| Net Income to Common Excl Extra Items | -$15M | -$850K | $5.9M | -$48.5M | -$25.2M | |
| Basic EPS (Cont. Ops) | -$556.29 | -$254.86 | -$272.02 | -$775.50 | -$430.25 | |
| Diluted EPS (Cont. Ops) | -$556.29 | -$254.86 | -$272.02 | -$775.50 | -$430.25 | |
| Weighted Average Basic Share | $60.2K | $78.3K | $94.5K | $97.6K | $170.4K | |
| Weighted Average Diluted Share | $60.2K | $78.3K | $94.5K | $97.6K | $170.4K | |
| EBITDA | $17.1M | $31.7M | $37.2M | $37.5M | $39.7M | |
| EBIT | -$4.3M | $11.6M | $16.7M | -$15.1M | $11.9M | |
| Revenue (Reported) | $77.2M | $90.9M | $101.9M | $119.3M | $124.5M | |
| Operating Income (Reported) | -$4M | $11.7M | $16.7M | -$11.4M | $15.5M | |
| Operating Income (Adjusted) | -$4.3M | $11.6M | $16.7M | -$15.1M | $11.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $18.9M | $24.8M | $28.9M | $34M | $32.3M | |
| Revenue Growth (YoY) | -26.07% | 31.27% | 16.67% | 17.59% | -5.01% | |
| Cost of Revenues | $9.6M | $12.4M | $17.1M | $19.5M | $18.8M | |
| Gross Profit | $9.3M | $12.4M | $11.8M | $14.5M | $13.5M | |
| Gross Profit Margin | 49.01% | 50.03% | 40.92% | 42.52% | 41.88% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.9M | $2.7M | $1.9M | $1.6M | $2.2M | |
| Other Inc / (Exp) | -- | $120K | -$1.5M | -$1M | -$1.2M | |
| Operating Expenses | $9.9M | $7.7M | $11.4M | $8.1M | $8.7M | |
| Operating Income | -$665K | $4.7M | $404K | $6.4M | $4.8M | |
| Net Interest Expenses | $2.6M | $2.2M | $6.2M | $9M | $9.8M | |
| EBT. Incl. Unusual Items | -$3.3M | $2.6M | -$7.3M | -$3.6M | -$6.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $374K | $307K | $256K | $270K | $121K | |
| Net Income to Company | -$3.7M | $2.3M | -$7.6M | -$3.9M | -$6.3M | |
| Minority Interest in Earnings | $1K | -$5K | $625K | $175K | $158K | |
| Net Income to Common Excl Extra Items | -$3.7M | $2.3M | -$7M | -$3.7M | -$6.1M | |
| Basic EPS (Cont. Ops) | -$127.62 | -$29.41 | -$137.23 | -$125.46 | -$20.73 | |
| Diluted EPS (Cont. Ops) | -$127.62 | -$29.41 | -$137.23 | -$125.46 | -$20.73 | |
| Weighted Average Basic Share | $63.8K | $95.3K | $92.7K | $98K | $574K | |
| Weighted Average Diluted Share | $63.8K | $95.3K | $92.7K | $98K | $574K | |
| EBITDA | $4.4M | $9.8M | $10M | $11.9M | $10.2M | |
| EBIT | -$665K | $4.8M | $404K | $5.3M | $3.6M | |
| Revenue (Reported) | $18.9M | $24.8M | $28.9M | $34M | $32.3M | |
| Operating Income (Reported) | -$665K | $4.7M | $404K | $6.4M | $4.8M | |
| Operating Income (Adjusted) | -$665K | $4.8M | $404K | $5.3M | $3.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $70.6M | $96.8M | $106M | $124.3M | $122.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $38.9M | $43.7M | $58.2M | $69.9M | $72M | |
| Gross Profit | $31.7M | $53.1M | $47.9M | $54.5M | $50.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.1M | $16M | $10.5M | $10.4M | $9.4M | |
| Other Inc / (Exp) | -$281K | $120K | -$1.7M | -$3.3M | -$3.8M | |
| Operating Expenses | $38.3M | $36.1M | $35.4M | $59.9M | $36.8M | |
| Operating Income | -$6.6M | $17M | $12.5M | -$5.4M | $14M | |
| Net Interest Expenses | $10.9M | $9M | $13.7M | $37.8M | $37.7M | |
| EBT. Incl. Unusual Items | -$17.8M | $8M | -$2.9M | -$46.5M | -$27.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$326K | $2.9M | $1.1M | $1.2M | $649K | |
| Net Income to Company | -$17.4M | $5.1M | -$3.9M | -$47.8M | -$28.1M | |
| Minority Interest in Earnings | $4K | -$5K | $603K | $2.5M | $558K | |
| Net Income to Common Excl Extra Items | -$17.4M | $5.1M | -$3.3M | -$45.3M | -$27.6M | |
| Basic EPS (Cont. Ops) | -$560.92 | -$178.90 | -$379.85 | -$790.68 | -$475.61 | |
| Diluted EPS (Cont. Ops) | -$560.92 | -$178.90 | -$379.85 | -$790.68 | -$475.61 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $14.3M | $37.2M | $37.4M | $40.9M | $38M | |
| EBIT | -$6.9M | $17M | $12.3M | -$8.7M | $10.2M | |
| Revenue (Reported) | $70.6M | $96.8M | $106M | $124.3M | $122.8M | |
| Operating Income (Reported) | -$6.6M | $17M | $12.5M | -$5.4M | $14M | |
| Operating Income (Adjusted) | -$6.9M | $17M | $12.3M | -$8.7M | $10.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $18.9M | $24.8M | $28.9M | $34M | $32.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.6M | $12.4M | $17.1M | $19.5M | $18.8M | |
| Gross Profit | $9.3M | $12.4M | $11.8M | $14.5M | $13.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.9M | $2.7M | $1.9M | $1.6M | $2.2M | |
| Other Inc / (Exp) | -- | $120K | -$1.5M | -$1M | -$1.2M | |
| Operating Expenses | $9.9M | $7.7M | $11.4M | $8.1M | $8.7M | |
| Operating Income | -$665K | $4.7M | $404K | $6.4M | $4.8M | |
| Net Interest Expenses | $2.6M | $2.2M | $6.2M | $9M | $9.8M | |
| EBT. Incl. Unusual Items | -$3.3M | $2.6M | -$7.3M | -$3.6M | -$6.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $374K | $307K | $256K | $270K | $121K | |
| Net Income to Company | -$3.7M | $2.3M | -$7.6M | -$3.9M | -$6.3M | |
| Minority Interest in Earnings | $1K | -$5K | $625K | $175K | $158K | |
| Net Income to Common Excl Extra Items | -$3.7M | $2.3M | -$7M | -$3.7M | -$6.1M | |
| Basic EPS (Cont. Ops) | -$127.62 | -$29.41 | -$137.23 | -$125.46 | -$20.73 | |
| Diluted EPS (Cont. Ops) | -$127.62 | -$29.41 | -$137.23 | -$125.46 | -$20.73 | |
| Weighted Average Basic Share | $63.8K | $95.3K | $92.7K | $98K | $574K | |
| Weighted Average Diluted Share | $63.8K | $95.3K | $92.7K | $98K | $574K | |
| EBITDA | $4.4M | $9.8M | $10M | $11.9M | $10.2M | |
| EBIT | -$665K | $4.8M | $404K | $5.3M | $3.6M | |
| Revenue (Reported) | $18.9M | $24.8M | $28.9M | $34M | $32.3M | |
| Operating Income (Reported) | -$665K | $4.7M | $404K | $6.4M | $4.8M | |
| Operating Income (Adjusted) | -$665K | $4.8M | $404K | $5.3M | $3.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $33.6M | $22.3M | $46.2M | $19.3M | $20.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.7M | $3.4M | $3.8M | $5.3M | $4.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $164.5M | $146.7M | $161.4M | $134.8M | $133.3M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | $12.4M | $33.5M | $33.7M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $6.3M | $5.3M | $4.5M | $3.9M | $3.6M | |
| Other Long-Term Assets | $8.8M | $10.9M | $10.1M | $14.2M | $9.8M | |
| Total Assets | $685.6M | $660.9M | $690.2M | $891.2M | $889.6M | |
| Accounts Payable | $20.3M | $26.8M | $107.2M | $26.4M | $32.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $27M | $31.3M | $110.4M | $71.3M | $74.1M | |
| Long-Term Debt | $324.3M | $201.1M | $184.3M | $430.2M | $477.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $361.7M | $249.5M | $312.5M | $514.4M | $562.5M | |
| Common Stock | $307.9M | $348.5M | $353.5M | $443.9M | $332.8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $15.6M | $62.5M | $23.9M | -$69.4M | -$7.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $455K | $345K | $373K | $2.4M | $1.7M | |
| Total Equity | $324M | $411.3M | $377.7M | $376.8M | $327.1M | |
| Total Liabilities and Equity | $685.6M | $660.9M | $690.2M | $891.2M | $889.6M | |
| Cash and Short Terms | $33.6M | $22.3M | $46.2M | $19.3M | $20.3M | |
| Total Debt | $324.3M | $201.1M | $184.3M | $471.6M | $505.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $34.6M | $17.1M | $22.5M | $21.3M | $19.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.6M | $3M | $8M | $6M | $3.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $166.4M | $148.7M | $151.2M | $135.7M | $125.3M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | $22.5M | $28.4M | $33.7M | $33.3M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $6M | $5M | $27.6M | $3.9M | $3.5M | |
| Other Long-Term Assets | $11.4M | $14.5M | $34.6M | $13.6M | $13.6M | |
| Total Assets | $685.9M | $688.3M | $957.6M | $887.5M | $882.3M | |
| Accounts Payable | $11.3M | $16M | $31.4M | $25.6M | $26.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $18.2M | $21.8M | $35.3M | $66.8M | $70.1M | |
| Long-Term Debt | $331.8M | $228.2M | $520.7M | $435M | $487.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $362.1M | $271.8M | $572M | $515.4M | $566.9M | |
| Common Stock | $315.9M | $356.7M | $374.8M | $454.8M | $325.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | $4.8M | $7.8M | -$65.2M | $9.3M | -$8K | |
| Minority Interest, Total | $340K | $350K | $4.8M | $2.2M | $1.6M | |
| Total Equity | $323.8M | $416.4M | $385.5M | $372.1M | $315.4M | |
| Total Liabilities and Equity | $685.9M | $688.3M | $957.6M | $887.5M | $882.3M | |
| Cash and Short Terms | $34.6M | $17.1M | $22.5M | $21.3M | $19.8M | |
| Total Debt | $331.8M | $228.2M | $520.7M | $472.8M | $512.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15M | -$851K | $5.9M | -$51.5M | -$25.8M | |
| Depreciation & Amoritzation | $21.1M | $20.2M | $20.5M | $52.7M | $27.7M | |
| Stock-Based Compensation | $222K | $220K | $202K | $183K | $220K | |
| Change in Accounts Receivable | -$419K | -$1.5M | -$480K | -$2M | $91K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $12.8M | $46.3M | $32.4M | $12M | $17M | |
| Capital Expenditures | $14.7M | $4M | $8.8M | $13.3M | $23.3M | |
| Cash Acquisitions | -- | -- | -$12.4M | -$14.3M | -$978K | |
| Cash From Investing | -$38.3M | -$12.7M | -$22.3M | -$88.7M | -$22.3M | |
| Dividends Paid (Ex Special Dividend) | -$21M | -$22M | -$32M | -$37.2M | -$31.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $77.5M | $35.4M | $166.2M | $389M | $209.7M | |
| Long-Term Debt Repaid | -$61.3M | -$159.7M | -$183.4M | -$281.3M | -$173.4M | |
| Repurchase of Common Stock | -$2.1M | -$2.8M | -$80.7M | -$106.1M | -$25.4M | |
| Other Financing Activities | -$2M | -$3.2M | -$4.5M | -$4.1M | -$6.1M | |
| Cash From Financing | $33.2M | -$43.6M | $13.7M | $63.4M | $13.9M | |
| Beginning Cash (CF) | $35.9M | $43.6M | $33.7M | $57.5M | $44.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.7M | -$10M | $23.8M | -$13.3M | $8.6M | |
| Ending Cash (CF) | $43.6M | $33.7M | $57.5M | $44.2M | $52.9M | |
| Levered Free Cash Flow | -$1.9M | $42.2M | $23.6M | -$1.3M | -$6.2M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $527K | $2.9M | -$18.4M | -$852K | -- | |
| Depreciation & Amoritzation | $5.1M | $5M | $20.5M | $6.5M | -- | |
| Stock-Based Compensation | $50K | $37K | $37K | $55K | -- | |
| Change in Accounts Receivable | -$553K | -$357K | $3.3M | $359K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.2M | $16.6M | $6.7M | $3.9M | -- | |
| Capital Expenditures | $449K | $2.2M | $1.6M | $2.1M | -- | |
| Cash Acquisitions | -- | -- | -$54K | -- | -- | |
| Cash From Investing | -$1.3M | -$2.7M | $13.4M | -$995K | -- | |
| Dividends Paid (Ex Special Dividend) | -$3.4M | -$4.9M | -$7.8M | -$9.8M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $15.4M | -- | $10.4M | $15M | -- | |
| Long-Term Debt Repaid | -$86.8M | -$20.7M | -$43.1M | -$2.8M | -- | |
| Repurchase of Common Stock | -$486K | -$2.5M | -$4.4M | -$7.8M | -- | |
| Other Financing Activities | -$445K | -$183K | -$985K | -$572K | -- | |
| Cash From Financing | $13.1M | -$16.9M | -$18.5M | $2.3M | -- | |
| Beginning Cash (CF) | $44.5M | $30.6M | $46.8M | $45.6M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $25M | -$2.9M | $1.5M | $5.2M | -- | |
| Ending Cash (CF) | $69.5M | $27.7M | $48.3M | $50.8M | -- | |
| Levered Free Cash Flow | $12.8M | $14.4M | $5M | $1.8M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$17.4M | $5.1M | -$3.9M | -$47.8M | -$28.1M | |
| Depreciation & Amoritzation | $21M | $20.2M | $25.1M | $49.6M | $27.8M | |
| Stock-Based Compensation | $226K | $215K | $202K | $183K | $220K | |
| Change in Accounts Receivable | -$655K | -$611K | -$5M | $1M | $1.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.5M | $50.3M | $26.5M | $10.8M | $16.6M | |
| Capital Expenditures | $9.5M | $6.1M | $11.2M | $10.2M | $27.9M | |
| Cash Acquisitions | -- | -$22.4M | $3.4M | -$8.2M | -$1.3M | |
| Cash From Investing | -$36.6M | -$42.2M | -$80.3M | $2M | -$27.1M | |
| Dividends Paid (Ex Special Dividend) | -$20.7M | -$23.2M | -$30.8M | -$35.1M | -$27.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $81M | $60.4M | $392.4M | $127.9M | $213.8M | |
| Long-Term Debt Repaid | -$57.9M | -$165.1M | -$279M | -$176.7M | -$171.8M | |
| Repurchase of Common Stock | -$2.6M | -$3.2M | -$168.4M | -$27.5M | -$15.2M | |
| Other Financing Activities | -$2.2M | -$3M | -$7M | -$1.8M | -$6M | |
| Cash From Financing | $36.5M | -$21.9M | $69.9M | -$14M | $13.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $11.3M | -$13.9M | $16.2M | -$1.2M | $3.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2M | $44.2M | $15.3M | $647K | -$11.3M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.1M | $5.2M | -$25.9M | -$4.8M | -$6.3M | |
| Depreciation & Amoritzation | $10.1M | $10.1M | $30.1M | $13.1M | $6.6M | |
| Stock-Based Compensation | $110K | $92K | $92K | $110K | $55K | |
| Change in Accounts Receivable | -$1.1M | $15K | -$848K | -$771K | $372K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $17.8M | $25.3M | $9.4M | $5.5M | $1.2M | |
| Capital Expenditures | $823K | $4.6M | $6.5M | $3.8M | $6.3M | |
| Cash Acquisitions | -- | -$22.4M | -$6.7M | -$530K | -$815K | |
| Cash From Investing | -$4.8M | -$35.7M | -$77.7M | -$1.4M | -$5.2M | |
| Dividends Paid (Ex Special Dividend) | -$15.2M | -$17.8M | -$19.6M | -$19.4M | -$6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $30.4M | $40M | $276.6M | $20M | $9M | |
| Long-Term Debt Repaid | -$94.6M | -$33.9M | -$151.9M | -$7M | -$2.6M | |
| Repurchase of Common Stock | -$1.2M | -$3.6M | -$93.3M | -$18.1M | -$8K | |
| Other Financing Activities | -$832K | -$406K | -$3.7M | -$944K | -$228K | |
| Cash From Financing | $12.9M | $4.5M | $59.1M | $2.5M | $206K | |
| Beginning Cash (CF) | $88.1M | $64.3M | $104.3M | $89.9M | $52.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $25.9M | -$6M | -$9.1M | $6.6M | -$3.7M | |
| Ending Cash (CF) | $114M | $58.3M | $95.2M | $96.5M | $49.1M | |
| Levered Free Cash Flow | $17M | $20.7M | $3M | $1.8M | -$5.1M | |
Get CMCT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CMCT
Sector
P/E ratio
--
19.72x
PEG ratio
0.00x
0.10x
P/B ratio
--
0.83x
Price / LTM sales
0.02x
3.52x
Growth Metrics
CMCT
Sector
Revenue growth
-5.01%
1.23%
Earnings growth
--
-1.15%
Revenue (5-year growth)
-2.32%
2.95%
Earnings forecast
-$0.55
$0.17
Profitability
CMCT
Sector
Profitability FY 2024
$51.7M
$203.5M
Return on invested capital
-3.3%
1.76%
Return on assets
-3.12%
1.52%
Return on equity
-8.01%
3.28%
Earnings Date
Last Earnings Date
May
9
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
8
Balance Sheet
CMCT
Sector
Total cash
$19.8M
$68M
Short term investments
--
$13.6M
Total assets
$889.6M
$3.3B
Long term debt
$512.7M
$1.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
